Alsterpaullone

Alsterpaullone is an inhibitor of CDK and CDK1 and related targets used in studies of Wnt Signaling and Cell Cycle Regulation and related signaling programs. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to beta-catenin-dependent transcription and developmental signaling and checkpoint control, mitotic progression, and proliferation timing in apoptosis, cancer, and cell cycle models.

By inhibiting CDK and CDK1 and related targets, Alsterpaullone can be used to examine beta-catenin-dependent transcription and developmental signaling and checkpoint control, mitotic progression, and proliferation timing. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CDK and CDK1 and related targets
• Pathway perturbation studies connected to Wnt Signaling and Cell Cycle Regulation and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, Alsterpaullone is appropriate when a defined chemical perturbant is needed to connect CDK and CDK1 and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.